Tag: Numinus - Psilocybin Alpha

New Resource: Psychedelics Drug Development Tracker

Numinus announces milestones in compassionate access trial for MDMA-assisted therapy in collaboration with MAPS Public Benefit Corporation

Post published:February 18, 2021
Post category:Press Release

Numinus Wellness Completes Acquisition of Montreal-based Mindspace Wellbeing

Numinus Wellness Completes Acquisition of Montreal-based Mindspace Wellbeing

Post published:February 8, 2021
Post category:Press Release

Numinus Wellness Closes Q1 2021 with Strong Cash Position and Industry Firsts

Post published:January 29, 2021
Post category:Press Release

Numinus Announces Listing of Warrants

Numinus Announces Listing of Warrants

Post published:January 22, 2021
Post category:Press Release

Numinus Announces Grant of Stock Options

Post published:January 14, 2021
Post category:Press Release

Numinus Wellness Forges Forward into Psychedelic Discovery Research with the Orbitrap Exploris 120 Mass Spectrometer

Post published:January 13, 2021
Post category:Press Release

Numinus Signs Lab Services Agreement with Optimi Health to Advance Research and Development of Psychedelic Products

Numinus Signs Lab Services Agreement with Optimi Health to Advance Research and Development of Psychedelic Products

Post published:January 6, 2021
Post category:Press Release

Numinus Announces Closing of $17 Million Bought Deal Offering Including Full Exercise of Over-Allotment Option

Numinus Announces Closing of $17 Million Bought Deal Offering Including Full Exercise of Over-Allotment Option

Post published:December 29, 2020
Post category:Press Release

Numinus Completes First Extraction of its Psilocybe Mushrooms

Numinus Completes First Extraction of its Psilocybe Mushrooms

Post published:December 17, 2020
Post category:Press Release

Pharmadrug Provides Corporate Update and Balance Sheet Status

Pharmadrug Provides Corporate Update and Balance Sheet Status

Post published:December 15, 2020
Post category:Press Release

End of content

No more pages to load

Psilocybin Alpha

The definitive resource for investors in the emergent psychedelic medicine sector. Cut through the shroom stock noise with exclusive news, interviews, data and private financing opportunities.

Quick Links

Newsletter

Industry insights and interviews delivered to your inbox. No spam, just valuable information.